202 related articles for article (PubMed ID: 28846693)
1. PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
Wang H; Qu Y; Dai B; Zhu Y; Shi G; Zhu Y; Shen Y; Zhang H; Ye D
PLoS One; 2017; 12(8):e0180862. PubMed ID: 28846693
[TBL] [Abstract][Full Text] [Related]
2. PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas.
Macher-Goeppinger S; Keith M; Tagscherer KE; Singer S; Winkler J; Hofmann TG; Pahernik S; Duensing S; Hohenfellner M; Kopitz J; Schirmacher P; Roth W
J Pathol; 2015 Dec; 237(4):460-71. PubMed ID: 26178300
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
Su Y; Zhou L; Yu Q; Lu J; Liu W
Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of MSP58 inhibits the proliferation and metastasis in human renal cell carcinoma cells.
Zhai X; Wu Y; Zhang D; Chong T; Zhao J
Biomed Pharmacother; 2017 Jul; 91():54-59. PubMed ID: 28448870
[TBL] [Abstract][Full Text] [Related]
5. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells.
Xiao X; Tang C; Xiao S; Fu C; Yu P
Oncol Res; 2013; 20(11):537-44. PubMed ID: 24063284
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.
Jöhrer K; Zelle-Rieser C; Perathoner A; Moser P; Hager M; Ramoner R; Gander H; Höltl L; Bartsch G; Greil R; Thurnher M
Clin Cancer Res; 2005 Apr; 11(7):2459-65. PubMed ID: 15814620
[TBL] [Abstract][Full Text] [Related]
9. TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.
Sun KH; Sun GH; Wu YC; Ko BJ; Hsu HT; Wu ST
J Cell Mol Med; 2016 Nov; 20(11):2020-2028. PubMed ID: 27297979
[TBL] [Abstract][Full Text] [Related]
10. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
11. PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
Chowdhury B; Porter EG; Stewart JC; Ferreira CR; Schipma MJ; Dykhuizen EC
PLoS One; 2016; 11(4):e0153718. PubMed ID: 27100670
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
13. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells.
Schüler Y; Lee-Thedieck C; Geiger K; Kaiser T; Ino Y; Aicher WK; Klein G
Int J Cancer; 2012 Jan; 130(2):288-99. PubMed ID: 21328336
[TBL] [Abstract][Full Text] [Related]
15. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside, disialosyl globopentaosylceramide (DSGb5), enhances the migration of renal cell carcinoma cells.
Kawasaki Y; Ito A; Kakoi N; Shimada S; Itoh J; Mitsuzuka K; Arai Y
Tohoku J Exp Med; 2015 May; 236(1):1-7. PubMed ID: 25864532
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
[TBL] [Abstract][Full Text] [Related]
18. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
20. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]